| Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells. | |
| | |
MedLine Citation:
|
PMID: 19211137 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Progesterone receptor (PR) expression is a favorable prognostic marker in ovarian cancer. We previously demonstrated that the induction of PR-B by treatment with cAMP was associated with G0/G1 arrest of the cell cycle and growth inhibition in NIH 3T3 cells. In this study, we examined the effect of cAMP treatment on cell growth in Ras-transformed NIH3T3 cells and ovarian cancer cells. METHODS: 1) The levels of PR-B and cell cycle associated proteins (p21, p27 and Rb) following treatment with cAMP in the Ras-transformed NIH3T3 cells (K12V) and ovarian cancer cell lines (SKOV cells) were investigated by Western blots. 2) The effects of PR overexpression following treatment with cAMP or after infection of an adenovirus expressing PR-B on cell growth and tumorigenicity in a soft agar culture were examined. RESULTS: 1) Treatment with cAMP increased PR-B and p27 levels in K12V cells and inhibited cell growth by inducing premature senescence. Induction of senescence was specific to the transformed cells. 2) In SKOV cells, treatment with cAMP induced PR-B, p27 and p21 expression, reduced the level of phosphorylated Rb, caused accumulation of cells in the G0/G1 fraction of the cell cycle, and induced senescence. 3) Both anchorage-dependent and -independent SKOV cell growths were inhibited by cAMP treatment. 4) Induction of both the expression and transcriptional activity of PR-B is critical for the induction of senescence and suppression of tumorigenicity. CONCLUSION: Treatment of cAMP, through activation of PR-B, induced senescence and suppressed tumorigenicity in ovarian cancer cells. |
| | |
Authors:
|
Akira Takahashi; Kiyoko Kato; Ayumi Kuboyama; Takafumi Inoue; Yoshihiro Tanaka; Aya Kuhara; Katsuyuki Kinoshita; Satoru Takeda; Norio Wake |
Related Documents
:
|
19372557 - Premature senescence is a major response to dna cross-linking agents in brca1-defective... 8026567 - Nuclear matrix composition and in vitro cellular senescence. 12143927 - Age does not influence dna fragmentation in the hippocampus after fatal traumatic brain... 9754577 - Anergic t cells actively suppress t cell responses via the antigen-presenting cell. 6641937 - Transport of sugars or amino acids increases potassium efflux from isolated enterocytes. 20477167 - Death of memory t-cell subsets in humans: changes during aging. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-02-10 |
Journal Detail:
|
Title: Gynecologic oncology Volume: 113 ISSN: 1095-6859 ISO Abbreviation: Gynecol. Oncol. Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-04-13 Completed Date: 2009-04-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0365304 Medline TA: Gynecol Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 270-6 Citation Subset: IM |
Affiliation:
|
Department of Molecular Genetics, Division of Molecular and Cell Therapeutics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Bucladesine / pharmacology* Cell Aging / drug effects Cell Line, Transformed Cell Line, Tumor Cyclin-Dependent Kinase Inhibitor p21 / biosynthesis Cyclin-Dependent Kinase Inhibitor p27 / biosynthesis Female Humans Mice NIH 3T3 Cells Ovarian Neoplasms / drug therapy, metabolism*, pathology Receptors, Progesterone / biosynthesis* Up-Regulation / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/CDKN1A protein, human; 0/Cyclin-Dependent Kinase Inhibitor p21; 0/Receptors, Progesterone; 0/progesterone receptor B; 147604-94-2/Cyclin-Dependent Kinase Inhibitor p27; 362-74-3/Bucladesine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Could scrotoschisis mimic an iatrogenic injury? A case report.
Next Document: Compressive strength of two newly developed glass-ionomer materials for use with the Atraumatic Rest...